PMA device
CareLink Instruments & DDMA, CareLink SmartSync Common Application
Medtronic, Inc. · Pulse Generator, Permanent, Implantable (NVZ, Class III) · First FDA decision Jan 24, 2006, newest Apr 20, 2023Bradycardia and heart blockHeart failure
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
12
PMA pathway
Device trials
12
Naming "CareLink"
MAUDE reports
95,315
Brand "CareLink", since 2015
PubMed studies
179
Mentioning "CareLink"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing CareLink Instruments & DDMA, CareLink SmartSync Common Application
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 12 decisions filed under this name.
P890003-S457 · Decided Apr 20, 2023 · 167 days after receipt · Normal 180 Day Track
Device type: Pulse generator, permanent, implantable (NVZ) · Cardiology
- CARELINK MONITOR MODEL 2490C, MODEL 24950; CARDIOSIGHT READER MODEL 2020A, CARELINK EXPRESS MONITOR 2020B, MODEL 2491 DDPMA supplement
P890003-S356 · Decided Oct 25, 2016 · 175 days after receipt · Normal 180 Day Track
Device type: Pulse generator, permanent, implantable (NVZ) · Cardiology
- CARELINK MONITOR MODELS 2490C AND 2491 DDMA, CARDIOSIGHT READER MODEL 2020A, CARELINK EXPRESS MONITOR 2020B, MYCARELINKPMA supplement
P890003-S354 · Decided Oct 12, 2016 · 180 days after receipt · Normal 180 Day Track
Device type: Pulse generator, permanent, implantable (NVZ) · Cardiology
3 more FDA decisions with a free account
Older decisions: P890003-S309, P890003-S252, P890003-S247, P890003-S169, P890003-S154, P890003-S084
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "CareLink", any status and sponsor, newest update first.
- Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)Active, not recruiting
MedtronicPublic (MDT)
NCT04496518 · 2,200 participants (planned) · Start Aug 1, 2020 · Primary completion Nov 6, 2024
Device: Intrinsic Antitachycardia Pacing (iATP) Therapy · For: Ventricular Tachycardia
Sites: Chandler, Arizona; Little Rock, Arkansas; Chula Vista, California · 92 sites in all
Medtronic Cardiac Rhythm and Heart FailurePublic (MDT)
NCT02401659 · 187 participants · Start May 2014 · Primary completion Oct 2017
Device: CareLinK · For: Arrythmia
Sites: Vitoria-Gasteiz, Spain; Barcelona, Spain; Madrid, Spain · 4 sites in all
- OptiLink HF Study: Optimization of Heart Failure Management Using Medtronic OptiVol Fluid Status Monitoring and CareLink NetworkPivotal-lookingCompleted
Medtronic Cardiac Rhythm and Heart FailurePublic (MDT)
NCT00769457 · 1,002 participants · Start Sep 2008 · Primary completion Nov 2014
Device: Access Arm · For: Heart Failure
Sites: Homburg-Saar, Germany
9 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "CareLink", and for the whole product code for context.
This brand
95,315 reports: 94,882 malfunction, 426 injury, 2 death
Whole product code NVZ
72,953 reports: 32,608 malfunction, 38,411 injury, 1,913 death
Newest reports for this brand
- Carelink Pro OnlineMalfunction
2032227-2026-264311 · Received Oct 30, 2026 · Event dated Sep 24, 2026
Device type: Continuous Glucose Monitor Retrospective Data Analysis Software (PHV)
Device problem as coded: Data Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- CareLink SmartSync Common App iOSMalfunction
2182208-2026-62427 · Received Oct 30, 2026 · Event dated Jun 4, 2025
Device type: Pacemaker/Icd/Crt Non-Implanted Components (OSR)
Device problem as coded: Computer Software Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- CareLink SmartSync Common App iOSMalfunction
2182208-2026-62428 · Received Oct 30, 2026 · Event dated Jun 4, 2025
Device type: Pacemaker/Icd/Crt Non-Implanted Components (OSR)
Device problem as coded: Computer Software Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- CareLink SmartSync Programmer, Model 24970A, Pulse generator, permanent, implantableOpen, Classified
Z-0302-2027 · Started Sep 24, 2026 · Posted by FDA Oct 27, 2026
Reason given: Software problem has the potential for an inaccurate displayed longevity estimate.
Cause as FDA categorized it: Software design · Device type: Pulse Generator, Permanent, Implantable (NVZ)
- CareLink SmartSync, RF Head Patient Connector, Model 24967, Pulse generator, permanent, implantableOpen, Classified
Z-0303-2027 · Started Sep 24, 2026 · Posted by FDA Oct 27, 2026
Reason given: Software problem has the potential for an inaccurate displayed longevity estimate.
Cause as FDA categorized it: Software design · Device type: Pulse Generator, Permanent, Implantable (NVZ)
- CareLink SmartSync Device Manager App, Model M01A02, Pulse generator, permanent, implantableOpen, Classified
Z-0304-2027 · Started Sep 24, 2026 · Posted by FDA Oct 27, 2026
Reason given: Software problem has the potential for an inaccurate displayed longevity estimate.
Cause as FDA categorized it: Software design · Device type: Pulse Generator, Permanent, Implantable (NVZ)
10 more recall records with a free account
Published research
The most relevant PubMed records for "CareLink"[tiab]. The summary above synthesizes these.
- Effect of Diactive-1 mHealth-Supported Progressive Resistance Training on Insulin Requirements, Glycemic Stability, and Muscular Strength in Children and Adolescents With Type 1 Diabetes: A Parallel-Group Randomized Controlled Trial.
Muñoz-Pardeza J, Hormazábal-Aguayo I, Huerta-Uribe N, et al. · Diabetes Care · 2025Randomized Controlled Trial
- Generating real-world evidence on diabetes technology using the CareLink Personal data management system.
van den Heuvel T, Castañeda J, Arrieta A, et al. · Diabetes Obes Metab · 2024Research Support, Non-U.S. Gov't
- CareLink-Corrections Phase 1: A Feasibility Study Inside Prisons to Improve Self-Care Upon Release.
Maruca AT, Reagan L, Shelton D · J Correct Health Care · 2021Clinical Trial, Phase I
- Baby CareLink: development and implementation of a WWW-based system for neonatal home telemedicine.
Gray J, Pompilio-Weitzner G, Jones PC, et al. · Proc AMIA Symp · 1998Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
- Implantable Cardioverter-Defibrillator Shocks During COVID-19 Outbreak.
Adabag S, Zimmerman P, Black A, et al. · J Am Heart Assoc · 2021Research Support, Non-U.S. Gov't
- Baby CareLink: using the internet and telemedicine to improve care for high-risk infants.
Gray JE, Safran C, Davis RB, et al. · Pediatrics · 2000Clinical Trial, Evaluation Study
- Performance of alert transmissions from cardiac implantable electronic devices to the CareLink network: A retrospective analysis.
Cronin EM, Green JC, Lande J, et al. · Cardiovasc Digit Health J · 2023
- Effectiveness of Medtronic CareLink Express System in identifying patients with high-energy electrotherapy devices requiring clinically significant intervention.
Grabowski M, Sadecka S, Cacko A, et al. · Cardiol J · 2018
- Pediatric Cancer CareLink--supporting home management of childhood leukemia.
Goldsmith DM, Silverman LB, Safran C · Proc AMIA Symp · 2002Evaluation Study, Research Support, U.S. Gov't, P.H.S.
- Effectiveness of a multicomponent intervention to reduce social isolation and loneliness in community-dwelling elders: A randomized clinical trial.
Hernández-Ascanio J, Perula-de Torres LÁ, Rich-Ruiz M, et al. · Nurs Open · 2023Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Socioeconomic Status Affects Pre- and Postoperative Two-point Discrimination in Patients with Carpal Tunnel Syndrome.
Prabhakar G, Ghali A, Momtaz D, et al. · Plast Reconstr Surg Glob Open · 2022
- Effect of Carelink, an internet-based insulin pump monitoring system, on glycemic control in rural and urban children with type 1 diabetes mellitus.
Corriveau EA, Durso PJ, Kaufman ED, et al. · Pediatr Diabetes · 2008Comparative Study, Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code NVZ.
- Affinity/Integrity/Victory/Zephyr/Accent Family of PacemakersAbbott Medical · PMA 2016
- Adapta, Versa, Sensia IPGEnPulse E1 IPG Kappa DR (Kappa 700/600)Medtronic, Inc. · PMA 2017
- Various Families of PacemakersMedtronic, Inc. · PMA 2008
- Cadence Family of IcdsAbbott Medical · PMA 2012
- Medtronic CareLink Monitor, CardioSight ReaderMedtronic, Inc. · PMA 2019
- Legend Plus Family of PacemakersMedtronic, Inc. · PMA 2011
- Advisa DR MRI SureScan Model A2DR01 IPG, Advisa SR MRI SureScan Model A3SR01 IPGMedtronic, Inc. · PMA 2022
- AdaptaMedtronic, Inc. · PMA 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.